Literature DB >> 17120048

Fine-mapping the putative chromosome 17q21-22 prostate cancer susceptibility gene to a 10 cM region based on linkage analysis.

Ethan M Lange1, Christiane M Robbins, Elizabeth M Gillanders, Siqun Lilly Zheng, Jianfeng Xu, Yunfei Wang, Kirsten A White, Bao-Li Chang, Lindsey A Ho, Jeffrey M Trent, John D Carpten, William B Isaacs, Kathleen A Cooney.   

Abstract

Prostate cancer linkage studies have suggested the existence of a prostate cancer susceptibility gene on chromosome 17q21-22. We now report the results of an extended linkage analysis including 95 new multiplex prostate cancer families and 9 additional microsatellite markers resulting in a maximum LOD score of 2.99 at approximately 81-82 cM for all 453 pedigrees. Results from these 95 new pedigrees provide additional support for a chromosome 17q21-22 prostate cancer susceptibility gene. Inclusion of the 9 additional markers significantly reduced the size of the candidate region, as defined using a 1-LOD support interval, especially when focusing analyses on subsets of pedigrees with four or more confirmed affecteds or average age of diagnosis less than or equal to 65 years. A novel subset analysis of only those families (n = 147) that had four or more prostate cancer cases and an average age of prostate cancer diagnosis < or = 65 years results in a maximum LOD score of 5.49 at 78 cM with a 1-LOD support interval of 10 cM. This large set of pedigrees with four more prostate cancer cases characterized by early-onset disease will serve as a useful resource for identifying the putative 17q21-22 prostate cancer susceptibility gene.

Entities:  

Mesh:

Year:  2006        PMID: 17120048     DOI: 10.1007/s00439-006-0274-2

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  19 in total

1.  Genome-wide scan for prostate cancer susceptibility genes in the Johns Hopkins hereditary prostate cancer families.

Authors:  Jianfeng Xu; Elizabeth M Gillanders; Sarah D Isaacs; Bao-Li Chang; Kathy E Wiley; S Lilly Zheng; MaryPat Jones; Derek Gildea; Erica Riedesel; Julie Albertus; Diana Freas-Lutz; Carol Markey; Deborah A Meyers; Patrick C Walsh; Jeffrey M Trent; William B Isaacs
Journal:  Prostate       Date:  2003-12-01       Impact factor: 4.104

2.  Genome-wide screen for prostate cancer susceptibility genes in men with clinically significant disease.

Authors:  Bao-Li Chang; Sarah D Isaacs; Kathy E Wiley; Elizabeth M Gillanders; S Lilly Zheng; Deborah A Meyers; Patrick C Walsh; Jeffrey M Trent; Jianfeng Xu; William B Isaacs
Journal:  Prostate       Date:  2005-09-01       Impact factor: 4.104

3.  Allele-sharing models: LOD scores and accurate linkage tests.

Authors:  A Kong; N J Cox
Journal:  Am J Hum Genet       Date:  1997-11       Impact factor: 11.025

4.  Prohibitin mutations are uncommon in prostate cancer families linked to chromosome 17q.

Authors:  K A White; E M Lange; A M Ray; K J Wojno; K A Cooney
Journal:  Prostate Cancer Prostatic Dis       Date:  2006-05-30       Impact factor: 5.554

5.  Prostate cancer and genetic susceptibility: a genome scan incorporating disease aggressiveness.

Authors:  Janet L Stanford; Shannon K McDonnell; Danielle M Friedrichsen; Erin E Carlson; Suzanne Kolb; Kerry Deutsch; Marta Janer; Lee Hood; Elaine A Ostrander; Daniel J Schaid
Journal:  Prostate       Date:  2006-02-15       Impact factor: 4.104

Review 6.  Prohibitin: a potential target for new therapeutics.

Authors:  Suresh Mishra; Leigh C Murphy; B L Gregoire Nyomba; Liam J Murphy
Journal:  Trends Mol Med       Date:  2005-04       Impact factor: 11.951

7.  Truncating BRCA1 mutations are uncommon in a cohort of hereditary prostate cancer families with evidence of linkage to 17q markers.

Authors:  Kimberly A Zuhlke; Jennifer J Madeoy; Jennifer Beebe-Dimmer; Kirsten A White; Angela Griffin; Ethan M Lange; Stephen B Gruber; Elaine A Ostrander; Kathleen A Cooney
Journal:  Clin Cancer Res       Date:  2004-09-15       Impact factor: 12.531

8.  Cancer statistics, 2006.

Authors:  Ahmedin Jemal; Rebecca Siegel; Elizabeth Ward; Taylor Murray; Jiaquan Xu; Carol Smigal; Michael J Thun
Journal:  CA Cancer J Clin       Date:  2006 Mar-Apr       Impact factor: 508.702

9.  Androgens target prohibitin to regulate proliferation of prostate cancer cells.

Authors:  Simon C Gamble; Michael Odontiadis; Jonathan Waxman; Jules A Westbrook; Michael J Dunn; Robin Wait; Eric W-F Lam; Charlotte L Bevan
Journal:  Oncogene       Date:  2004-04-15       Impact factor: 9.867

Review 10.  The complex genetic epidemiology of prostate cancer.

Authors:  Daniel J Schaid
Journal:  Hum Mol Genet       Date:  2004-01-28       Impact factor: 6.150

View more
  19 in total

1.  Fine-mapping the 2q37 and 17q11.2-q22 loci for novel genes and sequence variants associated with a genetic predisposition to prostate cancer.

Authors:  Virpi H Laitinen; Tommi Rantapero; Daniel Fischer; Elisa M Vuorinen; Teuvo L J Tammela; Tiina Wahlfors; Johanna Schleutker
Journal:  Int J Cancer       Date:  2014-11-08       Impact factor: 7.396

2.  Genetic heterogeneity in Finnish hereditary prostate cancer using ordered subset analysis.

Authors:  Claire L Simpson; Cheryl D Cropp; Tiina Wahlfors; Asha George; Marypat S Jones; Ursula Harper; Damaris Ponciano-Jackson; Teuvo Tammela; Johanna Schleutker; Joan E Bailey-Wilson
Journal:  Eur J Hum Genet       Date:  2012-09-05       Impact factor: 4.246

3.  Familial prostate cancer and HOXB13 founder mutations: geographic and racial/ethnic variations.

Authors:  Henry T Lynch; Trudy G Shaw
Journal:  Hum Genet       Date:  2012-09-22       Impact factor: 4.132

4.  Genome-wide linkage scan for prostate cancer susceptibility in Finland: evidence for a novel locus on 2q37.3 and confirmation of signal on 17q21-q22.

Authors:  Cheryl D Cropp; Claire L Simpson; Tiina Wahlfors; Nati Ha; Asha George; MaryPat S Jones; Ursula Harper; Damaris Ponciano-Jackson; Tiffany A Green; Teuvo L J Tammela; Joan Bailey-Wilson; Johanna Schleutker
Journal:  Int J Cancer       Date:  2011-04-20       Impact factor: 7.396

5.  Mutational landscape of candidate genes in familial prostate cancer.

Authors:  Anna M Johnson; Kimberly A Zuhlke; Chris Plotts; Shannon K McDonnell; Sumit Middha; Shaun M Riska; Daniel J Schaid; Stephen N Thibodeau; Julie A Douglas; Kathleen A Cooney
Journal:  Prostate       Date:  2014-08-11       Impact factor: 4.104

6.  Identification of a novel germline SPOP mutation in a family with hereditary prostate cancer.

Authors:  Kimberly A Zuhlke; Anna M Johnson; Scott A Tomlins; Nallasivam Palanisamy; John D Carpten; Ethan M Lange; William B Isaacs; Kathleen A Cooney
Journal:  Prostate       Date:  2014-05-06       Impact factor: 4.104

7.  Confirmation of the HOXB13 G84E germline mutation in familial prostate cancer.

Authors:  Joan P Breyer; T Grant Avritt; Kate M McReynolds; William D Dupont; Jeffrey R Smith
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2012-06-19       Impact factor: 4.254

8.  Chromosome 17q12 variants contribute to risk of early-onset prostate cancer.

Authors:  Albert M Levin; Mitchell J Machiela; Kimberly A Zuhlke; Anna M Ray; Kathleen A Cooney; Julie A Douglas
Journal:  Cancer Res       Date:  2008-08-15       Impact factor: 12.701

9.  HOXB13 mutations in a population-based, case-control study of prostate cancer.

Authors:  Marni Stott-Miller; Danielle M Karyadi; Tiffany Smith; Erika M Kwon; Suzanne Kolb; Janet L Stanford; Elaine A Ostrander
Journal:  Prostate       Date:  2012-11-05       Impact factor: 4.104

10.  Absence of truncating BRIP1 mutations in chromosome 17q-linked hereditary prostate cancer families.

Authors:  A M Ray; K A Zuhlke; G R Johnson; A M Levin; J A Douglas; E M Lange; K A Cooney
Journal:  Br J Cancer       Date:  2009-11-24       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.